About Biotechnology
26 Aug 2026Biotechnology is one of 6 industries in the Healthcare sector. Solomo tracks 6 listed companies classified as Biotechnology on India's NSE and BSE, out of 335 in the Healthcare sector. Their combined market capitalisation was ₹46,805 crore on 26 Aug 2026, 1.3% of the Healthcaresector's total and the 4th largest of its 6 industries by market value. All 6 carry both an NSE symbol and a BSE scrip code.
The 3 largest by market capitalisation are Anthem Biosciences Ltd (₹42,510 crore), Advanced Enzyme Technologies Ltd (₹3,692 crore) and CCME Global Ltd (₹520 crore).
Median trailing P/E across the 5 companies with a reported ratio is 42.2, and median return on capital employed (ROCE) across 6 companies is 3.8%.
| Company | Market cap | P/E | ROCE |
|---|---|---|---|
| Anthem Biosciences Ltd | ₹42,510 Cr | 71.8 | 26.7% |
| Advanced Enzyme Technologies Ltd | ₹3,692 Cr | 21.9 | 14.1% |
| CCME Global Ltd | ₹520 Cr | — | -1.8% |
| Vivo Bio Tech Ltd | ₹52 Cr | — | 6.6% |
| Shree Ganesh Biotech India Ltd | ₹22 Cr | 42.2 | 0.8% |
| Genomic Valley Biotech Ltd | ₹9.14 Cr | 299.3 | 1.0% |
Other industries in Healthcare: Pharmaceuticals (218), Hospital (37), Healthcare Service Provider (37), Healthcare Research, Analytics & Technology (11) and Medical Equipment & Supplies (26).
Market capitalisation, P/E and ROCE are from Solomo's fundamentals snapshot dated 26 Aug 2026; the interactive table above re-prices market cap and P/E against live quotes during market hours, so intraday figures there will differ. Sector and industry labels follow the NSE and BSE classification, and any market-cap rank quoted above is taken across Solomo's full NSE and BSE universe. Reference data, not investment advice.